1
|
Brandelli YN, Mackinnon SP, Chambers CT, Parker JA, Huber AM, Stinson JN, Johnson SA, Wilson JP. Exploring Pain Adaptation in Youth With Juvenile Idiopathic Arthritis: Identifying Youth and Parent Resilience Resources and Mechanisms. Arthritis Care Res (Hoboken) 2024. [PMID: 39308005 DOI: 10.1002/acr.25439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Revised: 08/13/2024] [Accepted: 09/11/2024] [Indexed: 10/27/2024]
Abstract
OBJECTIVE Although juvenile idiopathic arthritis (JIA) is often associated with pain, this experience does not necessitate negative outcomes (eg, depression, functional impairment). Little research has explored youth and parent resilience resources (ie, stable traits) and mechanisms (ie, dynamic processes) in this context, and studies have focused on their contributions independently rather than collectively. This study, informed by the Ecological Resilience-Risk Model in Pediatric Chronic Pain, sought to (1) explore the relationships among youth and parent resilience resources and mechanisms and (2) identify the relative importance (RI; ie, independent contributions when entered simultaneously) of evidence-based youth and parent resources and mechanisms in contributing to youth-reported recovery, sustainability, and growth outcomes. METHODS Youth (13-18 years) with JIA and their parents (156 dyads) completed a battery of online questionnaires assessing resilience resources (optimism, resilience), mechanisms (psychological flexibility, pain acceptance, self-efficacy), recovery and sustainability (pain intensity, functional disability, health-related quality of life), and growth (benefit finding) outcomes. RESULTS Analyses demonstrated significant positive correlations across within-person resources and mechanisms and weaker correlations across within-dyad resources and mechanisms. Although the RI of predictors varied by outcome, youth pain acceptance was the most robust predictor across models (RI = 0.03-0.15). Some predictors (eg, parent psychological flexibility and pain acceptance) were generally categorized as "Not Important," whereas others (eg, youth resilience) had "Inconclusive" results, suggesting construct overlap. CONCLUSION Although additional research is needed to further understand resilience, results highlight the importance of fostering pain acceptance in youth and incorporating parents in psychosocial interventions to optimize living with JIA.
Collapse
Affiliation(s)
| | | | | | | | - Adam M Huber
- Dalhousie University and IWK Health, Halifax, Nova Scotia, Canada
| | - Jennifer N Stinson
- University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada
| | | | - Jennifer P Wilson
- Cassie and Friends: A Society for Children with Juvenile Arthritis and other Rheumatic Diseases, Vancouver, British Columbia, Canada
| |
Collapse
|
2
|
Neu E, Sears C, Brandon T, Kohlheim M, Leal J, Archie K, Holland E, Holland M, Hameed A, Khan A, Murphy L, Murphy S, Neu A, Neu J, Neu J, Richmond R, Suplee D, Suplee T, Forrest CB, Weiss PF. Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA) trial. Health Expect 2022; 26:290-296. [PMID: 36398414 PMCID: PMC9854298 DOI: 10.1111/hex.13655] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 06/27/2022] [Accepted: 10/21/2022] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA) study is a randomized, pragmatic trial investigating different tumour necrosis factor inhibitor de-escalation strategies for children with sustained inactive disease. In this project, we elicited concept rankings that aided in the selection of the patient-reported outcome (PRO) measures that should be examined as part of the BACK-OFF JSpA trial. METHODS We conducted a discrete choice experiment to evaluate individuals' preferences regarding PROs. Stakeholders assessed a discrete list of 21 outcome concepts, each of which had a Patient-Reported Outcome Measurement Information System (PROMIS) measure associated with it. PROMIS measures are self- or proxy-reported instruments that are universally applicable to the general population and all chronic conditions. Stakeholders were required to make choices instead of expressing the strength of a preference. RESULTS Fourteen caregivers, 12 patients (9-22 years old), 16 rheumatologists and three executives from health insurance companies completed the exercise, which took approximately 10 min. The discrete choice experiment resulted in an estimate of the relative importance of each outcome and rank. All stakeholder groups agreed that the primary PRO should be 'Pain Interference', a measure that evaluates the effect of pain on a child's everyday activities, including its impact on social, emotional, mental and physical functioning. Patients and caregivers were mostly aligned in their top priorities, with patients valuing physical health (50% of the top 10) whereas caregivers were more interested in mental health (60% of the top 10). Rheumatologists and health insurance executives were most interested in physical health outcomes, which were ranked 80% and 60% of their top 10 PROs, respectively. Overall, the patients had the most diverse set of prioritized outcomes, including at least one of each category in their top 10 rank order of importance. Patients were also the only stakeholders to prioritize 'social' health. CONCLUSIONS Patients and caregivers were mostly aligned in their outcome priority rankings. The rank-order list directly informed the creation of a profile of PRO measures for our upcoming trial. PATIENT OR PUBLIC CONTRIBUTION Stakeholder partners helped with acquisition of data and lead parent partners helped interpret data.
Collapse
Affiliation(s)
- Emily Neu
- Department of Pediatrics, Division of Rheumatology, Clinical Futures: A CHOP Research Institute Center of EmphasisChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Cora Sears
- Department of Pediatrics, Division of Rheumatology, Clinical Futures: A CHOP Research Institute Center of EmphasisChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Timothy Brandon
- Department of Pediatrics, Division of Rheumatology, Clinical Futures: A CHOP Research Institute Center of EmphasisChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Melanie Kohlheim
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Jenny Leal
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Kweli Archie
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - English Holland
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Miles Holland
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Aamena Hameed
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Asad Khan
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Lynn Murphy
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Sean Murphy
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Antoinette Neu
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Jerome Neu
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Justin Neu
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Rachel Richmond
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Dylan Suplee
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Theresa Suplee
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Christopher B. Forrest
- BACK‐OFF JSpA Research Partners GroupChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Pamela F. Weiss
- Department of Pediatrics, Division of Rheumatology, Clinical Futures: A CHOP Research Institute Center of EmphasisChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA,Department of Pediatrics and Epidemiology, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| |
Collapse
|
3
|
Sivaratnam S, Hwang K, Chee-A-Tow A, Ren L, Fang G, Jibb L. Using Social Media to Engage Knowledge Users in Health Research Priority Setting: Scoping Review. J Med Internet Res 2022; 24:e29821. [PMID: 35188476 PMCID: PMC8902657 DOI: 10.2196/29821] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 11/25/2021] [Accepted: 12/23/2021] [Indexed: 12/16/2022] Open
Abstract
Background
The need to include individuals with lived experience (ie, patients, family members, caregivers, researchers, and clinicians) in health research priority setting is becoming increasingly recognized. Social media–based methods represent a means to elicit and prioritize the research interests of such individuals, but there remains sparse methodological guidance on how best to conduct these social media efforts and assess their effectiveness.
Objective
This review aims to identify social media strategies that enhance participation in priority-setting research, collate metrics assessing the effectiveness of social media campaigns, and summarize the benefits and limitations of social media–based research approaches, as well as recommendations for prospective campaigns.
Methods
We searched PubMed, Embase, Cochrane Library, Scopus, and Web of Science from database inception until September 2021. Two reviewers independently screened all titles and abstracts, as well as full texts for studies that implemented and evaluated social media strategies aimed at engaging knowledge users in research priority setting. We subsequently conducted a thematic analysis to aggregate study data by related codes and themes.
Results
A total of 23 papers reporting on 22 unique studies were included. These studies used Facebook, Twitter, Reddit, websites, video-calling platforms, emails, blogs, e-newsletters, and web-based forums to engage with health research stakeholders. Priority-setting engagement strategies included paid platform–based advertisements, email-embedded survey links, and question-and-answer forums. Dissemination techniques for priority-setting surveys included snowball sampling and the circulation of participation opportunities via internal members’ and external organizations’ social media platforms. Social media campaign effectiveness was directly assessed as number of clicks and impressions on posts, frequency of viewed posts, volume of comments and replies, number of times individuals searched for a campaign page, and number of times a hashtag was used. Campaign effectiveness was indirectly assessed as numbers of priority-setting survey responses and visits to external survey administration sites. Recommendations to enhance engagement included the use of social media group moderators, opportunities for peer-to-peer interaction, and the establishment of a consistent tone and brand.
Conclusions
Social media may increase the speed and reach of priority-setting participation opportunities leading to the development of research agendas informed by patients, family caregivers, clinicians, and researchers. Perceived limitations of the approach include underrepresentation of certain demographic groups and addressing such limitations will enhance the inclusion of diverse research priority opinions in future research agendas.
Collapse
Affiliation(s)
- Surabhi Sivaratnam
- Michael G Degroote School of Medicine, McMaster University, Hamilton, ON, Canada
- Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, ON, Canada
| | - Kyobin Hwang
- Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, ON, Canada
- Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
| | | | - Lily Ren
- Lane Medical Library, Stanford University, Stanford, CA, United States
| | - Geoffrey Fang
- Faculty of Applied Science and Engineering, University of Toronto, Toronto, ON, Canada
| | - Lindsay Jibb
- Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, ON, Canada
- Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
4
|
Zigler CK, Randell RL, Reeve BB. Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases: Considerations and Future Directions. Rheum Dis Clin North Am 2022; 48:15-29. [PMID: 34798944 PMCID: PMC9311483 DOI: 10.1016/j.rdc.2021.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
For children with pediatric rheumatic diseases (PRDs), the inclusion of patient-reported outcomes (PROs) is critical to inform decision making in health care delivery and research settings. PROs are direct reports from a child on their health status, without interpretation by anyone else. PROs improve understanding of the patient experience, allow clinicians to provide patient-centered care, and add value to clinical trials. When PROs cannot be collected directly from the patient, caregiver-proxy reports can provide important information on the child's more observable symptoms and functioning. In this article, we describe the current use of PROs in specific PRDs, align current research with best practice recommendations for both clinical care and research settings, highlight exciting new developments, and identify areas for future research.
Collapse
Affiliation(s)
- Christina K. Zigler
- Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina
| | - Rachel L. Randell
- Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina
| | - Bryce B. Reeve
- Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.,Pediatrics, Duke University School of Medicine, Durham, North Carolina
| |
Collapse
|
6
|
Verwoerd A, Armbrust W, Cowan K, van den Berg L, de Boer J, Bookelman S, Britstra M, Cappon J, Certan M, Dedding C, van den Haspel K, Muller PH, Jongsma K, Lelieveld O, van Loosdregt J, Olsder W, Rocha J, Schatorjé E, Schouten N, Swart JF, Vastert S, Walter M, Schoemaker CG. Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2021; 19:52. [PMID: 33827608 PMCID: PMC8028801 DOI: 10.1186/s12969-021-00540-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Accepted: 03/23/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Involving the end-users of scientific research (patients, carers and clinicians) in setting research priorities is important to formulate research questions that truly make a difference and are in tune with the needs of patients. We therefore aimed to generate a national research agenda for Juvenile Idiopathic Arthritis (JIA) together with patients, their caregivers and healthcare professionals through conducting a nationwide survey among these stakeholders. METHODS The James Lind Alliance method was used, tailored with additional focus groups held to involve younger patients. First, research questions were gathered through an online and hardcopy survey. The received questions that were in scope were summarised and a literature search was performed to verify that questions were unanswered. Questions were ranked in the interim survey, and the final top 10 was chosen during a prioritisation workshop. RESULTS Two hundred and seventy-eight respondents submitted 604 questions, of which 519 were in scope. Of these 604 questions, 81 were generated in the focus groups with younger children. The questions were summarised into 53 summary questions. An evidence checking process verified that all questions were unanswered. A total of 303 respondents prioritised the questions in the interim survey. Focus groups with children generated a top 5 of their most important questions. Combining this top 5 with the top 10s of patients, carers, and clinicians led to a top 21. Out of these, the top 10 research priorities were chosen during a final workshop. Research into pain and fatigue, personalised treatment strategies and aetiology were ranked high in the Top 10. CONCLUSIONS Through this study, the top 10 research priorities for JIA of patients, their caregivers and clinicians were identified to inform researchers and research funders of the research topics that matter most to them. The top priority involves the treatment and mechanisms behind persisting pain and fatigue when the disease is in remission.
Collapse
Affiliation(s)
- Anouk Verwoerd
- grid.7692.a0000000090126352Centre for Translational Immunology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands ,grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands
| | - Wineke Armbrust
- grid.4494.d0000 0000 9558 4598University of Groningen, University Medical Centre Groningen, Department of Paediatric Rheumatology and Immunology, Beatrix Children’s Hospital, Hanzeplein 1, 9713 GZ Groningen, The Netherlands ,Dutch Society for Paediatric Rheumatology (NVKR), Mercatorlaan 1200, 3528 BL Utrecht, The Netherlands
| | - Katherine Cowan
- grid.5491.90000 0004 1936 9297James Lind Alliance, National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC), based at the University of Southampton, Alpha House, Enterprise Road, Southampton, SO16 7NS UK
| | - Lotte van den Berg
- Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands
| | - Joke de Boer
- grid.7692.a0000000090126352Department of Ophthalmology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - Sanne Bookelman
- Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands
| | - Marjan Britstra
- Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands
| | - Jeannette Cappon
- grid.418029.60000 0004 0624 3484Reade, Centre for Rehabilitation and Rheumatology, Dr. Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands ,Dutch Health Professionals in Paediatric Rheumatology (NHPKR), Amsterdam, The Netherlands
| | - Maria Certan
- grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands ,grid.5477.10000000120346234Department of Science, University College Roosevelt, Lange Noordstraat 1, 4331 CB Middelburg, The Netherlands
| | - Christine Dedding
- Department of Medical Humanities, Amsterdam University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
| | - Karin van den Haspel
- Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands
| | - Petra Hissink Muller
- Dutch Society for Paediatric Rheumatology (NVKR), Mercatorlaan 1200, 3528 BL Utrecht, The Netherlands ,Department of Paediatric Immunology and Rheumatology, Willem-Alexander Children’s Hospital, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Karin Jongsma
- grid.7692.a0000000090126352Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - Otto Lelieveld
- Dutch Health Professionals in Paediatric Rheumatology (NHPKR), Amsterdam, The Netherlands ,University of Groningen, University Medical Centre Groningen, Department of Rehabilitation Medicine, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
| | - Jorg van Loosdregt
- grid.7692.a0000000090126352Centre for Translational Immunology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands ,grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands
| | - Wendy Olsder
- Youth-R-Well.com, Patient Organisation for Young Patients, member of EULAR PARE, Eikstraat 3, 3434 TD Nieuwegein, The Netherlands
| | - Johanna Rocha
- Youth-R-Well.com, Patient Organisation for Young Patients, member of EULAR PARE, Eikstraat 3, 3434 TD Nieuwegein, The Netherlands
| | - Ellen Schatorjé
- Dutch Society for Paediatric Rheumatology (NVKR), Mercatorlaan 1200, 3528 BL Utrecht, The Netherlands ,grid.461578.9Department of Paediatric Immunology and Rheumatology, Amalia Children’s Hospital, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands ,Department of Paediatric Rheumatology, St. Maartenskliniek, Dokter Kopstraat 1, 5835 DV Beugen, The Netherlands
| | - Natasja Schouten
- Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands
| | - Joost F. Swart
- grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands ,Dutch Society for Paediatric Rheumatology (NVKR), Mercatorlaan 1200, 3528 BL Utrecht, The Netherlands
| | - Sebastiaan Vastert
- grid.7692.a0000000090126352Centre for Translational Immunology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands ,grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands ,Dutch Society for Paediatric Rheumatology (NVKR), Mercatorlaan 1200, 3528 BL Utrecht, The Netherlands
| | - Margot Walter
- Dutch Health Professionals in Paediatric Rheumatology (NHPKR), Amsterdam, The Netherlands ,grid.5645.2000000040459992XDepartment of Rheumatology, Erasmus University Medical Centre, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
| | - Casper G. Schoemaker
- grid.417100.30000 0004 0620 3132Department of Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, Lundlaan 6, 3584 EA Utrecht, The Netherlands ,Dutch JIA Patient and Parent Organisation (JVN), member of ENCA, Pius X-straat 49, 5121 EP Rijen, The Netherlands ,grid.5477.10000000120346234Faculty of Medicine, Utrecht University, Universiteitsweg 98, 3584 CG Utrecht, The Netherlands
| |
Collapse
|